共 50 条
- [31] A MULTI-INSTITUTIONAL ANALYSIS OF PATIENT OUTCOMES FOLLOWING INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT FOR NON-MUSCLE INVASIVE BLADDER CANCER [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E524 - E524
- [36] Methylation status as a predictor of intravesical Bacillus Calmette-Guerin (BCG) immunotherapy response of high grade non-muscle invasive bladder tumor [J]. BIOMEDICAL PAPERS-OLOMOUC, 2017, 161 (02): : 210 - 216
- [37] Intravesical Bacillus Calmette-Guerin (BCG) Therapy for Non-muscle Invasive Bladder Cancers: Long-term Results of a Modified Schedule [J]. Indian Journal of Surgical Oncology, 2021, 12 : 796 - 801
- [39] Bacillus Calmette-Guerin (BCG) and alternatives Drug treatment of high-risk non-muscle invasive bladder cancer [J]. UROLOGE, 2021, 60 (11): : 1400 - 1408